SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,277.91 260.82
(0.53%)

Dow Jones

6,942.18 0.25
(0.00%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.93 -0.23
(-0.25%)

EUR-INR

105.10 -0.46
(-0.44%)

GBP-INR

121.29 -0.65
(-0.53%)

JPY-INR

0.57 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Shopping Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

32.7094199

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

224.52

EPS(TTM)

Face Value()

Div & Yield %

6.2

0.49

Back

meghna infracon infrastructure ltd

CCL Products (India) consolidated net profit rises 36.39% in the September 2025 quarter

Nov 06,2025

Net profit of CCL Products (India) rose 36.39% to Rs 100.86 crore in the quarter ended September 2025 as against Rs 73.95 crore during the previous quarter ended September 2024. Sales rose 52.63% to Rs 1126.73 crore in the quarter ended September 2025 as against Rs 738.20 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1126.73	738.20	53
OPM %	17.50	18.57	-
PBDT	165.98	111.00	50
PBT	127.09	87.31	46
NP	100.86	73.95	36

83,576.24 -604.72 ( -0.72%)

49,277.91 260.82 (0.53%)

6,942.18 0.25 (0.00%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.93 -0.23 (-0.25%)

105.10 -0.46 (-0.44%)

121.29 -0.65 (-0.53%)

0.57 0.00 (-0.31%)